. 2022 Jan 4;12(5):2171–2192. doi: 10.1016/j.apsb.2021.12.022
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 8.
Chemical structures of ERK1/2 inhibitors 34‒40.